Growth hormone–releasing peptides
CJC-1295, Ipamorelin
These compounds are studied for their ability to stimulate pituitary growth hormone (GH) release through GHRH-like or ghrelin-receptor pathways, depending on the peptide. Preclinical and some clinical work explores effects on body composition, recovery, and metabolic markers; potency, duration, and side-effect profiles differ by molecule. Research use is distinct from approved medicines, and quality of evidence varies widely by peptide and endpoint.